Financial

Catheter Precision Names Fatih Ayoglu as Business Development Manager—EMEA

MT. OLIVE, N.J. & CARLSBAD, Calif.–(BUSINESS WIRE)–Catheter Precision, Inc., a medical device and technology company focused on cardiac electrophysiology, announces the appointment of Fatih Ayoglu to the newly created position of Business Development Manager—EMEA. Mr. Ayoglu will oversee clinical and sales development of Catheter Precision products in Europe, the Middle […]

SomaLogic’s Chief Medical Officer Steve Williams honored with C-Suite Award by the Denver Business Journal

BOULDER, Colo., Sept. 26, 2022 (GLOBE NEWSWIRE) — SomaLogic (NASDAQ: SLGC), a leader in AI data-driven proteomics technology, today announced that Chief Medical Officer Steve Williams, M.D., Ph.D., has been named a 2022 C-Suite Award winner by the Denver Business Journal. The honorees in the Denver Business Journal’s 2022 C-Suite […]

CareDx Congratulates Board Member Dr. Grace Colón for Being Named Healthcare Innovator on Top 50 Most Powerful Latinas List

The Association of Latino Professionals For America Recognizes the Most Powerful Latinas in Business, Technology, Healthcare, and Non-Profit Sectors BRISBANE, Calif.–(BUSINESS WIRE)–CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced […]

HARMONY BIOSCIENCES ANNOUNCES 2022 FUNDING RECIPIENTS OF PATIENTS AT THE HEART AND PROGRESS AT THE HEART AWARD PROGRAMS

PLYMOUTH MEETING, Pa., Sept. 22, 2022 /PRNewswire/ — Harmony Biosciences Holdings, Inc. (“Harmony”) (NASDAQ: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases, today announced on the fourth annual World Narcolepsy Day, the funding recipients of its Patients at the Heart and Progress at the Heart award programs. The Patients […]

Rivus Pharmaceuticals Closes $132 Million Series B Financing to Advance HU6 for the Treatment of Obesity and Cardio-Metabolic Disorders

Financing led by RA Capital Management with participation from Bain Capital Life Sciences, BB Biotech AG and Series A investors Longitude Capital, Medicxi and RxCapital CHARLOTTESVILLE, Va., Sept. 22, 2022 /PRNewswire/ — Rivus Pharmaceuticals Inc., a clinical-stage biopharmaceutical company dedicated to improving cardio-metabolic health, today announced the completion of a $132 million Series B financing led […]

US Heart & Vascular Welcomes Mike Englehart as Chief Executive Officer

USHV’s Leadership Team Grows to Strengthen its Mission to Partner with Cardiovascular Physicians Focused on High Quality Care in Support of Long-Term Goals for National Footprint Expansion NASHVILLE, Tenn.–(BUSINESS WIRE)–US Heart & Vascular (“USHV”), a leading national provider of support services to cardiovascular physician practices, announced today that Mike Englehart […]

iRhythm Technologies Details Growth Strategies at 2022 Analyst & Investor Day

SAN FRANCISCO, Sept. 21, 2022 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent and predict disease, will discuss the Company’s strategies for long-term growth, provide an update on its innovation pipeline and share its financial goals […]

Medtronic announces closing of public offering of €3.5 billion of senior notes

DUBLIN, Sept. 21, 2022 /PRNewswire/ — Medtronic plc (the “Company”) ( NYSE: MDT) today announced that its wholly-owned subsidiary Medtronic Global Holdings S.C.A. ( “Medtronic Luxco”) has closed a registered public offering (the “Offering”) of €500,000,000 principal amount of 2.625% Senior Notes due 2025, €1,000,000,000 principal amount of 3.000% Senior Notes due 2028, €1,000,000,000 […]

Ra Medical Systems Announces Results of its Special Meeting of Stockholders and a 1-for-50 Reverse Stock Split

CARLSBAD, Calif.–(BUSINESS WIRE)–Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or the “Company”) announces that at its virtual Special Meeting of Stockholders held today, the Company’s stockholders approved all three proposals on the proxy filed with the Securities and Exchange Commission on August 29, 2022. The Company also announces that its […]

Medical 21 secures up to $20 million commitment for its pioneering cardiac bypass technology

Globally recognized entrepreneur and medical device developer Manny Villafaña PhD Sc. secures additional financing to accelerate his latest venture. MINNEAPOLIS, Sept. 20, 2022 /PRNewswire/ — Medical 21, a medtech company aiming to transform heart bypass surgery with a revolutionary artificial graft, says it has successfully closed a $20 million commitment pursuant to Regulation D, […]